Connable Office Inc Danaher Corp Transaction History

Connable Office Inc

  • $981 Million
  • Q3 2024

A detailed history of Connable Office Inc transactions in Danaher Corp stock. As of the latest transaction made, Connable Office Inc holds 14,130 shares of DHR stock, worth $3.33 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
14,130
Previous 14,077 0.38%
Holding current value
$3.33 Million
Previous $3.52 Million 11.66%
% of portfolio
0.4%
Previous 0.38%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
BUY
$239.25 - $280.76 $12,680 - $14,880
53 Added 0.38%
14,130 $3.93 Million
Q2 2024

Aug 06, 2024
SELL
$235.51 - $267.98 $82,192 - $93,525
-349 Reduced 2.42%
14,077 $3.52 Million
Q1 2024

Apr 30, 2024
SELL
$224.58 - $256.19 $531,356 - $606,145
-2,366 Reduced 14.09%
14,426 $3.6 Million
Q4 2023

Feb 12, 2024
SELL
$185.1 - $233.13 $20,731 - $26,110
-112 Reduced 0.66%
16,792 $3.88 Million
Q3 2023

Nov 08, 2023
SELL
$233.08 - $265.59 $582,466 - $663,709
-2,499 Reduced 12.88%
16,904 $4.19 Million
Q2 2023

Aug 07, 2023
BUY
$224.99 - $256.14 $454,479 - $517,402
2,020 Added 11.62%
19,403 $4.66 Million
Q1 2023

Apr 17, 2023
SELL
$239.75 - $277.0 $74,562 - $86,147
-311 Reduced 1.76%
17,383 $4.38 Million
Q4 2022

Jan 23, 2023
BUY
$241.42 - $282.29 $45,628 - $53,352
189 Added 1.08%
17,694 $4.7 Million
Q3 2022

Oct 26, 2022
SELL
$247.06 - $1507.4 $104,506 - $637,630
-423 Reduced 2.36%
17,505 $4.52 Million
Q2 2022

Aug 01, 2022
SELL
$237.11 - $299.66 $59,277 - $74,915
-250 Reduced 1.38%
17,928 $4.55 Million
Q1 2022

May 12, 2022
BUY
$257.27 - $315.76 $89,272 - $109,568
347 Added 1.95%
18,178 $5.33 Million
Q4 2021

Feb 14, 2022
SELL
$292.08 - $329.01 $28,915 - $32,571
-99 Reduced 0.55%
17,831 $5.87 Million
Q3 2021

Nov 09, 2021
SELL
$272.21 - $332.43 $304,602 - $371,989
-1,119 Reduced 5.87%
17,930 $5.46 Million
Q2 2021

Aug 06, 2021
SELL
$225.08 - $271.69 $54,244 - $65,477
-241 Reduced 1.25%
19,049 $5.11 Million
Q1 2021

May 07, 2021
SELL
$212.38 - $245.9 $563,656 - $652,618
-2,654 Reduced 12.09%
19,290 $4.34 Million
Q4 2020

Feb 09, 2021
BUY
$212.5 - $245.46 $93,075 - $107,511
438 Added 2.04%
21,944 $4.88 Million
Q3 2020

Nov 10, 2020
SELL
$177.16 - $215.33 $6,732 - $8,182
-38 Reduced 0.18%
21,506 $4.63 Million
Q2 2020

Aug 10, 2020
SELL
$128.7 - $176.83 $1.05 Million - $1.44 Million
-8,123 Reduced 27.38%
21,544 $3.81 Million
Q1 2020

May 08, 2020
SELL
$121.39 - $169.05 $92,620 - $128,985
-763 Reduced 2.51%
29,667 $4.11 Million
Q4 2019

Feb 07, 2020
SELL
$133.47 - $153.48 $167,371 - $192,463
-1,254 Reduced 3.96%
30,430 $4.67 Million
Q3 2019

Nov 12, 2019
BUY
$135.4 - $146.47 $42,244 - $45,698
312 Added 0.99%
31,684 $4.58 Million
Q2 2019

Aug 06, 2019
SELL
$124.88 - $143.73 $320,566 - $368,954
-2,567 Reduced 7.56%
31,372 $4.48 Million
Q1 2019

May 07, 2019
SELL
$97.62 - $132.29 $462,230 - $626,393
-4,735 Reduced 12.24%
33,939 $4.48 Million
Q4 2018

Feb 12, 2019
BUY
$94.85 - $109.54 $818,460 - $945,220
8,629 Added 28.72%
38,674 $3.99 Million
Q2 2018

Aug 07, 2018
BUY
$96.1 - $103.24 $164,138 - $176,333
1,708 Added 6.03%
30,045 $2.97 Million
Q1 2018

May 08, 2018
BUY
$92.16 - $103.8 $19,906 - $22,420
216 Added 0.77%
28,337 $2.77 Million
Q4 2017

Feb 07, 2018
SELL
$85.26 - $94.62 $9,122 - $10,124
-107 Reduced 0.38%
28,121 $2.61 Million
Q3 2017

Nov 03, 2017
BUY
$79.29 - $88.45 $2.24 Million - $2.5 Million
28,228
28,228 $2.42 Million

Others Institutions Holding DHR

# of Institutions
2,508
Shares Held
542M
Call Options Held
7.07M
Put Options Held
4.55M
View Full List

About DANAHER CORP

DHR Quotes by TradingView
  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $172B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Connable Office Inc Portfolio

Follow Connable Office Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connable Office Inc, based on Form 13F filings with the SEC.

News

Stay updated on Connable Office Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email